Composition capable of conditioning female endocrine and delaying senescence and preparation method of composition

Abstract

The invention relates to a composition capable of conditioning female endocrine and delaying senescence and a preparation method of the composition. The composition capable of conditioning the femaleendocrine and delaying the senescence is prepared from, by weight, 3.68-5.52 parts of fructus gardeniae, 3.52-5.28 parts of cynanchum auriculatum royle, 3.2-4.8 parts of radix levistic officinalis, 8-12 parts of multi-pedal red roses, 40-60 parts of cranberry and 21.6-32.4 parts of isomaltitol. The composition can effectively regulate the endocrine, prevent or treat the symptoms such as dysphoria,irritability, insomnia, dreaminess, dizziness, tinnitus, dysphoria in chestpalms-soles, waist soreness and bone pain caused by decreased estrogen in the perimenopause, menopause and postmenopause, and have the effects of ameliorating wrinkles and hyperpigmentation and delaying the senescence. The composition capable of conditioning the female endocrine and delaying the senescence and the preparation method of the composition have the advantages that the safety is high, the adaptability is wide, the preparation process is simple, the efficiency is high, no pollution exists, and the preparationmethod meets the large-scale production requirements, and is suitable for popularization and application.

Description

technical field [0001] The invention belongs to the technical field of health care products, and in particular relates to a composition for regulating female endocrine and delaying aging and a preparation method thereof. Background technique [0002] Female climacteric syndrome is a series of symptoms caused by the decline of estrogen levels, including upset and irritability, insomnia, dreaminess, dizziness, tinnitus, five upset fever, hot sweating, edema and loose stools, palpitations, palpitations, backaches, emotional exception etc. Menopausal syndrome mostly occurs in women aged 40-60, that is, the transitional period when women's ovarian function gradually declines to disappear completely. Most women in this age group may experience symptoms of menopausal syndrome ranging from severity to severity, and about 85% of them can self-control. Relief, about 15% of women have severe symptoms, affecting life and work, and need treatment. In addition, young women may also expe...

AI Technical Summary

Problems solved by technology

Such as the use of hormone replacement therapy (HRT) to treat menopausal syndrome in women, but the potential risks of this treatment cannot be ignored. Its contraindications include those with a history of estrogen-dependent tumors, such as endometrial cancer, breast cancer, etc. Women with cancer; women with previous or existing thromboembolism, such as stroke, myocardial infarction; severe liver and kidney dysfunction, heart failure, severe diabetes with vascular lesions, uterine fibroids, endometriosis, and unexplained vaginal bleeding etc.

Images